<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03075176</url>
  </required_header>
  <id_info>
    <org_study_id>IRB # 95434</org_study_id>
    <nct_id>NCT03075176</nct_id>
  </id_info>
  <brief_title>Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy</brief_title>
  <official_title>Outcomes of Topography-guided LASIK and Photorefractive Keratectomy Compared to Wavefront Optimized LASIK and Photorefractive Keratectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the difference in results between eyes that have been treated wavefront
      optimized laser vision correction (either LASIK or Photorefractive Keratectomy) compared to
      eyes treated with topography-guided laser vision correction (either LASIK or Photorefractive
      Keratectomy). Each participant will receive wavefront optimized correction in one eye and
      topography-guided correction in the other.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 13, 2017</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Each participant will receive wavefront optimized surgery in one eye and topography-guided surgery in the second eye.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participants will be masked as to which type of surgery they receive in either eye.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in uncorrected visual acuity from baseline to month 12</measure>
    <time_frame>12 months</time_frame>
    <description>Uncorrected visual acuity will be tested pre-operatively through month 12</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in contrast sensitivity from baseline to month 3</measure>
    <time_frame>3 months</time_frame>
    <description>Contrast sensitivity will be tested pre-operatively and 3 months post-operatively</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in degree of higher order aberrations from baseline to 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>Aberrometry measurements will be taken pre-operatively and 3 months post surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in quality of life score from baseline to 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>The validated Quality of Life Impact of Refractive Correction survey will be administered pre-operatively and 3 months post surgery</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Surgery</condition>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Wavefront optimized LASIK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wavefront optimized Photorefractive Keratectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Topography-guided LASIK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Topography-guided Photorefractive Keratectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wavefront optimized LASIK</intervention_name>
    <description>Wavefront optimized laser vision correction</description>
    <arm_group_label>Wavefront optimized LASIK</arm_group_label>
    <arm_group_label>Topography-guided LASIK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wavefront optimized Photorefractive Keratectomy</intervention_name>
    <description>Wavefront optimized laser vision correction</description>
    <arm_group_label>Wavefront optimized Photorefractive Keratectomy</arm_group_label>
    <arm_group_label>Topography-guided Photorefractive Keratectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Topography-guided LASIK</intervention_name>
    <description>Topography-guided laser vision correction</description>
    <arm_group_label>Wavefront optimized LASIK</arm_group_label>
    <arm_group_label>Topography-guided LASIK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Topography-guided Photorefractive Keratectomy</intervention_name>
    <description>Topography-guided laser vision correction</description>
    <arm_group_label>Wavefront optimized Photorefractive Keratectomy</arm_group_label>
    <arm_group_label>Topography-guided Photorefractive Keratectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All subjects who are deemed suitable candidates for laser refractive surgery after
             routine refractive surgery screening will be considered eligible for participation in
             this study.

        Subjects must be at least 21 years of age and not pregnant or nursing (due to fluctuations
        in visual parameters during pregnancy)

        Exclusion Criteria:

          -  Any patient who is not a suitable candidate for LASIK or PRK will not be included.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Mifflin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah Moran Eye Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christopher B Smith, MD</last_name>
    <phone>801-585-3937</phone>
    <email>christopherb.smith@hsc.utah.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Myrna Church</last_name>
    <phone>801-585-3937</phone>
    <email>Myrna.Church@hsc.utah.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Moran Eye Center - Midvalley Location</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Mifflin, MD</last_name>
      <phone>801-583-3447</phone>
      <email>Mark.Mifflin@hsc.utah.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2017</study_first_submitted>
  <study_first_submitted_qc>March 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2017</study_first_posted>
  <last_update_submitted>May 20, 2018</last_update_submitted>
  <last_update_submitted_qc>May 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Mark Mifflin</investigator_full_name>
    <investigator_title>Professor, Ophthalmology/Visual Sciences</investigator_title>
  </responsible_party>
  <keyword>Photorefractive keratectomy</keyword>
  <keyword>Laser-assisted in situ keratomileusis</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

